Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AUPHNASDAQ:BGMNASDAQ:ETNB On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAUPHAurinia Pharmaceuticals$8.05+2.8%$8.04$5.20▼$10.67$1.06B1.151.32 million shs1.41 million shsBGMBGM Group$12.91-1.6%$12.49$5.26▼$17.17$1.28B1.3832,789 shs107,613 shsETNB89BIO$9.81-1.9%$8.69$4.16▼$11.84$1.46B1.31.51 million shs1.15 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAUPHAurinia Pharmaceuticals+2.81%+1.77%-0.37%-5.52%+42.23%BGMBGM Group-1.60%+2.06%-11.94%+11.01%+1,290,999,900.00%ETNB89BIO-1.90%-1.31%+3.37%+22.32%+16.09%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAUPHAurinia Pharmaceuticals3.3247 of 5 stars3.52.00.00.04.00.81.9BGMBGM GroupN/AN/AN/AN/AN/AN/AN/AN/AETNB89BIO2.1082 of 5 stars3.53.00.00.01.10.80.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAUPHAurinia Pharmaceuticals 3.00Buy$11.5042.86% UpsideBGMBGM Group 0.00N/AN/AN/AETNB89BIO 3.00Buy$26.43169.40% UpsideCurrent Analyst Ratings BreakdownLatest IMU, ETNB, AUPH, and BGM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/11/2025ETNB89BIOWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (D-) ➝ Sell (D-)5/24/2025ETNB89BIOWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (D-) ➝ Sell (D-)5/10/2025ETNB89BIOWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (D-) ➝ Sell (D-)4/30/2025ETNB89BIOCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/24/2025ETNB89BIOWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (D-) ➝ Sell (D-)4/8/2025ETNB89BIOWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (D-) ➝ Sell (D-)(Data available from 6/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAUPHAurinia Pharmaceuticals$235.13M4.63$0.32 per share25.39$2.68 per share3.00BGMBGM Group$25.10M50.00N/AN/A$7.34 per share1.76ETNB89BION/AN/AN/AN/A$3.34 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAUPHAurinia Pharmaceuticals$5.75M$0.2828.7514.38N/A16.11%14.27%9.93%7/30/2025 (Estimated)BGMBGM Group-$1.44MN/A0.00∞N/AN/AN/AN/AN/AETNB89BIO-$367.08M-$3.38N/AN/AN/AN/A-81.44%-70.17%8/4/2025 (Estimated)Latest IMU, ETNB, AUPH, and BGM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2025Q1 2025AUPHAurinia Pharmaceuticals$0.08$0.16+$0.08$0.16$61.06 million$62.47 million5/1/2025Q1 2025ETNB89BIO-$0.50-$0.49+$0.01-$0.49N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAUPHAurinia PharmaceuticalsN/AN/AN/AN/AN/ABGMBGM GroupN/AN/AN/AN/AN/AETNB89BION/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAUPHAurinia Pharmaceuticals0.165.935.26BGMBGM GroupN/A3.392.82ETNB89BIO0.0618.0318.03Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAUPHAurinia Pharmaceuticals36.83%BGMBGM GroupN/AETNB89BION/AInsider OwnershipCompanyInsider OwnershipAUPHAurinia Pharmaceuticals12.20%BGMBGM Group58.66%ETNB89BIO2.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAUPHAurinia Pharmaceuticals300135.10 million118.62 millionOptionableBGMBGM Group29897.22 million40.19 millionN/AETNB89BIO40145.98 million141.90 millionOptionableIMU, ETNB, AUPH, and BGM HeadlinesRecent News About These Companies89BIO (NASDAQ:ETNB) Given Average Recommendation of "Buy" by AnalystsJune 25 at 4:43 AM | marketbeat.comAssenagon Asset Management S.A. Increases Holdings in 89bio, Inc. (NASDAQ:ETNB)June 16, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Trading Up 4.9% - What's Next?June 13, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Shares Down 4.8% - Here's What HappenedJune 12, 2025 | marketbeat.comHarbor Capital Advisors Inc. Buys 62,874 Shares of 89bio, Inc. (NASDAQ:ETNB)June 12, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Receives Sell (D-) Rating from Weiss RatingsJune 12, 2025 | marketbeat.comBrokers Offer Predictions for 89bio FY2026 EarningsJune 11, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCJune 9, 2025 | marketbeat.comHennion & Walsh Asset Management Inc. Raises Position in 89bio, Inc. (NASDAQ:ETNB)June 7, 2025 | marketbeat.com89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 6, 2025 | globenewswire.com89bio to Participate in Goldman Sachs 46th Annual Global Healthcare ConferenceJune 4, 2025 | globenewswire.comTwo Sigma Investments LP Sells 131,167 Shares of 89bio, Inc. (NASDAQ:ETNB)June 3, 2025 | marketbeat.comTwo Sigma Advisers LP Reduces Holdings in 89bio, Inc. (NASDAQ:ETNB)June 2, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Shares Bought by Bank of America Corp DEJune 2, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Given Consensus Recommendation of "Buy" by BrokeragesJune 1, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Shares Up 6.4% - Still a Buy?May 30, 2025 | marketbeat.com89bio (ETNB) Receives a Buy from Bank of America SecuritiesMay 29, 2025 | theglobeandmail.com89bio (NASDAQ:ETNB) Shares Gap Up - Here's What HappenedMay 29, 2025 | marketbeat.comMillennium Management LLC Has $5.54 Million Stock Holdings in 89bio, Inc. (NASDAQ:ETNB)May 29, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Stock Price Down 3.3% - Here's What HappenedMay 28, 2025 | marketbeat.com89bio's (ETNB) "Sell (D-)" Rating Reaffirmed at Weiss RatingsMay 28, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeIMU, ETNB, AUPH, and BGM Company DescriptionsAurinia Pharmaceuticals NASDAQ:AUPH$8.05 +0.22 (+2.81%) Closing price 06/24/2025 04:00 PM EasternExtended Trading$8.15 +0.10 (+1.29%) As of 04:26 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.BGM Group NASDAQ:BGM$12.91 -0.21 (-1.60%) Closing price 06/24/2025 03:59 PM EasternExtended Trading$12.96 +0.05 (+0.39%) As of 08:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. Qilian International Holding Group Limited was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.89BIO NASDAQ:ETNB$9.81 -0.19 (-1.90%) Closing price 06/24/2025 04:00 PM EasternExtended Trading$9.81 0.00 (-0.04%) As of 06/24/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis; and for the treatment of severe hypertriglyceridemia. The company was incorporated in 2018 and is headquartered in San Francisco, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Hot Trades for Insiders, But Are They Good Buys for Investors? Why Qualcomm’s Latest Price Target Can't Be Ignored Texas Instruments Stock: Congress Likes It, Should You Too? Geospace Stock Skyrockets After Major Petrobras Contract Analyst Sees Meta Hitting $800: What May Lead Shares to New Highs CrowdStrike Eyes Breakout as Cyber Threats Boost Demand Reddit Stock Ignites: Surge in Call Options Signals Big Bet Insiders Chase Income and Stability in American Tower—Here’s Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
